| Views | |
|---|---|
| Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | 60 |
| February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | |
|---|---|---|---|---|---|---|---|
| Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | 3 | 2 | 0 | 5 | 4 | 9 | 0 |
| Views | |
|---|---|
| Netrebenko_Assessment.pdf | 20 |
| Views | |
|---|---|
| United States | 14 |
| Canada | 8 |
| Australia | 2 |
| Japan | 2 |
| Brazil | 1 |
| Czech Republic | 1 |
| Germany | 1 |
| EU | 1 |
| Hong Kong | 1 |
| South Korea | 1 |
| Views | |
|---|---|
| Ottawa | 8 |
| Mountain View | 3 |
| San Francisco | 3 |
| Kanda | 2 |
| Washington | 2 |
| Ann Arbor | 1 |
| Bala Cynwyd | 1 |
| Baltimore | 1 |
| Central District | 1 |
| Coburg | 1 |